Vanta Bioscience Ltd. Corporate Filings & Announcements

Latest corporate announcements and filings from Vanta Bioscience Ltd. on BSE

Load latest

Vanta Bioscience Ltd.

07 Apr 2022

Company Update

Vanta Bioscience Ltd - 540729 - Statement Of Investor Complaints For The Quarter Ended March 2022

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb S SayaniDesignation :- Company Secretary and Compliance Officer

Vanta Bioscience Ltd.

04 Apr 2022

Company Update

Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 …

BSE India

Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company

pdf

Vanta Bioscience Ltd.

31 Mar 2022

SAST

Vanta Bioscience Ltd - 540729 - Closure of Trading Window

BSE India

As per the provisions of the code of conduct and policies for prevention of Insider Trading of the Company, the trading window for transactions in shares of the Company for all designated persons and their immediate relatives will be closed from April 01, 2022 till the 48 hours after the declaration of audited financial results of the Company for the half year and year ended March 31, 2022. The date of Board Meeting for consideration of audited financial results of the Company for the half year and year ended March 31, 2022 shall be intimated in due course of time

pdf

Vanta Bioscience Ltd.

17 Mar 2022, 07:47PM

Company Update

Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 …

BSE India

Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company

pdf

Vanta Bioscience Ltd.

04 Mar 2022

Company Update

Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 …

BSE India

Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company

pdf

Vanta Bioscience Ltd.

25 Feb 2022

Company Update

Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 …

BSE India

Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company

pdf

Vanta Bioscience Ltd.

15 Jan 2022

Company Update

Vanta Bioscience Ltd - 540729 - Statement Of Investor Complaints For The Quarter Ended December 2021

BSE India

No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Zoheb SayaniDesignation :- Company Secretary and Compliance Officer

Vanta Bioscience Ltd.

04 Jan 2022

Company Update

Vanta Bioscience Ltd - 540729 - Announcement under Regulation 30 (LODR)-Award of Order Receipt of Order

BSE India

Receipt of order for testing/studies from Coromandel International Limited

pdf

Vanta Bioscience Ltd.

04 Jan 2022

Company Update

Vanta Bioscience Ltd - 540729 - Update In The Matter Of NCLT Application Under Section 9 …

BSE India

Update In The Matter Of NCLT Application Under Section 9 Of Insolvency And Bankruptcy Code, 2016 - C.P. (IB) - 215/2021 Filed Against The Company

pdf

Vanta Bioscience Ltd.

31 Dec 2021

AGM

Vanta Bioscience Ltd - 540729 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)

BSE India

Vanta Bioscience Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here

Is Vanta Bioscience Ltd. worth buying?

4 Votes:

Buy 75.0%

Sell 25.0%